Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larazotide acetate in active celiac disease
NCT00620451Phase 2Completed
- Sponsor
- Innovate Biopharmaceuticals
- Start
- Feb 2008
- Primary completion
- Jul 2009
- Countries
- 3
01
Overview
A Phase 2 trial of larazotide in celiac disease, sponsored by Innovate Biopharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
larazotide
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT00620451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620451.